United States · Who invested in NKT Therapeutics?
NKT Therapeutics's investors include SV Life Sciences and MedImmune Ventures.
2010
$8.0MSeries A$4.0MVentureUnited States · Venture startup
Who invested in NKT Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 2 rounds since 2009, from 2 sources
$8.0MSeries A$4.0MVenture
- Latest round
- Venture, $4.0MAug 2010
- Biggest round
- $8.0MSeries A · Mar 2009
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $8.0M Mar 2009
- Biggest round
- $8.0M Series A · Mar 2009
- Between rounds
- 17 months from the last two
The rounds
- Aug 2010Venture$4.0M
No investor was named in the report.
Reported by masshightech.comSEC filing: $4.0M sold, first sale Aug 2010
- Mar 2009
Founders and team
From the SEC filings it signed: 2 on the team.
- Alemseged TrunehExecutive Officeri
- Robert MashalExecutive Officer, Director, Promoteri
On the board, as filediDavid J. HungMaggie J. LeFloreMichael J. Ross
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Quick answers about NKT Therapeutics
How much has NKT Therapeutics raised?
NKT Therapeutics has raised $12M across 2 rounds since 2009.
When did NKT Therapeutics last raise?
NKT Therapeutics's most recent round was a Venture of $4.0M in Aug 2010.
What was NKT Therapeutics's biggest round?
NKT Therapeutics's largest round on record is $8.0M (Series A), in Mar 2009.
Who backed NKT Therapeutics first?
NKT Therapeutics's first round on record, in Mar 2009, was backed by SV Life Sciences and MedImmune Ventures.
What stage is NKT Therapeutics at?
NKT Therapeutics's latest named round is a Venture, in Aug 2010.
Where is NKT Therapeutics based?
NKT Therapeutics is based in the United States.
Companies like NKT Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.